BRENUS PHARMA

Brenus Pharma is a pioneering french biotech startup reshaping the landscape of oncology with our innovative platform, generating cutting-edge cancer vaccines. Our Stimulated Tumor Cells (STC) technology platform empowers the immune system to anticipate tumor cell plasticity and target relapse mechanisms, offering a game-changing approach to preventing cancer recurrence. We break through current limitations by efficiently treating solid tumors, ensuring cost and supply control. Our lead candidate, STC-1010, is focused on colorectal cancer, addressing a significant unmet medical need. Join us in revolutionizing solid tumor treatment with our groundbreaking technology.